The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates

Ähnliche Einträge

• Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification
  von: Nancy M. Heddle, et al.
  Veröffentlicht: (2024)
• Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials
  von: Joan Cid, et al.
  Veröffentlicht: (2024)
• Characterization of a novel mouse platelet transfusion model
  von: Dominique Gordy, et al.
  Veröffentlicht: (2024)
• Enhanced O 2 availability in platelet concentrates stored for neonatal transfusion is independent of agitation: Evidence from direct oximetry and Fickian diffusion modelling
  von: Dean Pym, et al.
  Veröffentlicht: (2025)
• Introduction of 7‐day amotosalen/ultraviolet A light pathogen‐reduced platelets in Honduras: Impact on platelet availability in a lower middle‐income country
  von: Marcelo Pedraza, et al.
  Veröffentlicht: (2024)